nodes	percent_of_prediction	percent_of_DWPC	metapath
Methazolamide—CA1—esophageal cancer	0.449	0.569	CbGaD
Methazolamide—CA2—esophageal cancer	0.341	0.431	CbGaD
Methazolamide—Acetazolamide—CA1—esophageal cancer	0.00417	0.569	CrCbGaD
Methazolamide—CA6—exocrine gland—esophageal cancer	0.00342	0.164	CbGeAlD
Methazolamide—Acetazolamide—CA2—esophageal cancer	0.00316	0.431	CrCbGaD
Methazolamide—Hepatic insufficiency—Methotrexate—esophageal cancer	0.00205	0.0909	CcSEcCtD
Methazolamide—CA7—trachea—esophageal cancer	0.00136	0.065	CbGeAlD
Methazolamide—CA2—exocrine gland—esophageal cancer	0.00118	0.0563	CbGeAlD
Methazolamide—CA7—digestive system—esophageal cancer	0.00117	0.0559	CbGeAlD
Methazolamide—CA9—digestive system—esophageal cancer	0.00102	0.0491	CbGeAlD
Methazolamide—CA4—neck—esophageal cancer	0.000907	0.0434	CbGeAlD
Methazolamide—CA12—trachea—esophageal cancer	0.000881	0.0422	CbGeAlD
Methazolamide—CYP2C9—Capecitabine—esophageal cancer	0.000844	0.451	CbGbCtD
Methazolamide—CA12—digestive system—esophageal cancer	0.000758	0.0363	CbGeAlD
Methazolamide—CA2—neck—esophageal cancer	0.000752	0.036	CbGeAlD
Methazolamide—Appetite absent—Methotrexate—esophageal cancer	0.000639	0.0283	CcSEcCtD
Methazolamide—CA12—lung—esophageal cancer	0.000633	0.0303	CbGeAlD
Methazolamide—Bone marrow depression—Capecitabine—esophageal cancer	0.000632	0.028	CcSEcCtD
Methazolamide—SLC22A6—Methotrexate—esophageal cancer	0.000601	0.321	CbGbCtD
Methazolamide—CA1—digestive system—esophageal cancer	0.000601	0.0288	CbGeAlD
Methazolamide—CA5B—lung—esophageal cancer	0.000568	0.0272	CbGeAlD
Methazolamide—Body temperature increased—Carboplatin—esophageal cancer	0.000557	0.0246	CcSEcCtD
Methazolamide—CA4—trachea—esophageal cancer	0.000546	0.0261	CbGeAlD
Methazolamide—Tingling sensation—Capecitabine—esophageal cancer	0.000531	0.0235	CcSEcCtD
Methazolamide—CA2—epithelium—esophageal cancer	0.000512	0.0245	CbGeAlD
Methazolamide—CA2—bronchus—esophageal cancer	0.000504	0.0241	CbGeAlD
Methazolamide—CA1—lung—esophageal cancer	0.000502	0.024	CbGeAlD
Methazolamide—CA2—smooth muscle tissue—esophageal cancer	0.000493	0.0236	CbGeAlD
Methazolamide—Polyuria—Cisplatin—esophageal cancer	0.000479	0.0212	CcSEcCtD
Methazolamide—Bone marrow depression—Methotrexate—esophageal cancer	0.000471	0.0208	CcSEcCtD
Methazolamide—CA4—digestive system—esophageal cancer	0.000469	0.0225	CbGeAlD
Methazolamide—Haemolytic anaemia—Cisplatin—esophageal cancer	0.000466	0.0206	CcSEcCtD
Methazolamide—CA2—trachea—esophageal cancer	0.000452	0.0217	CbGeAlD
Methazolamide—CYP2C9—Cisplatin—esophageal cancer	0.000425	0.227	CbGbCtD
Methazolamide—CYP2C19—digestive system—esophageal cancer	0.000425	0.0203	CbGeAlD
Methazolamide—Melaena—Capecitabine—esophageal cancer	0.000417	0.0185	CcSEcCtD
Methazolamide—CA4—lung—esophageal cancer	0.000392	0.0188	CbGeAlD
Methazolamide—CA2—digestive system—esophageal cancer	0.000389	0.0186	CbGeAlD
Methazolamide—CA5B—lymph node—esophageal cancer	0.000388	0.0186	CbGeAlD
Methazolamide—Urine output increased—Capecitabine—esophageal cancer	0.000386	0.0171	CcSEcCtD
Methazolamide—Polyuria—Capecitabine—esophageal cancer	0.000353	0.0156	CcSEcCtD
Methazolamide—Photosensitivity—Capecitabine—esophageal cancer	0.000353	0.0156	CcSEcCtD
Methazolamide—Pancytopenia—Cisplatin—esophageal cancer	0.000345	0.0153	CcSEcCtD
Methazolamide—Hepatic failure—Capecitabine—esophageal cancer	0.000345	0.0153	CcSEcCtD
Methazolamide—Haemolytic anaemia—Capecitabine—esophageal cancer	0.000343	0.0152	CcSEcCtD
Methazolamide—CA1—lymph node—esophageal cancer	0.000343	0.0164	CbGeAlD
Methazolamide—CYP2C9—digestive system—esophageal cancer	0.000329	0.0158	CbGeAlD
Methazolamide—CA2—lung—esophageal cancer	0.000325	0.0156	CbGeAlD
Methazolamide—CYP2E1—digestive system—esophageal cancer	0.000312	0.015	CbGeAlD
Methazolamide—Melaena—Methotrexate—esophageal cancer	0.00031	0.0137	CcSEcCtD
Methazolamide—Aplastic anaemia—Methotrexate—esophageal cancer	0.000298	0.0132	CcSEcCtD
Methazolamide—Urine output increased—Methotrexate—esophageal cancer	0.000287	0.0127	CcSEcCtD
Methazolamide—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000279	0.0124	CcSEcCtD
Methazolamide—Tinnitus—Cisplatin—esophageal cancer	0.000271	0.012	CcSEcCtD
Methazolamide—CA4—lymph node—esophageal cancer	0.000268	0.0128	CbGeAlD
Methazolamide—Photosensitivity—Methotrexate—esophageal cancer	0.000263	0.0116	CcSEcCtD
Methazolamide—Polyuria—Methotrexate—esophageal cancer	0.000263	0.0116	CcSEcCtD
Methazolamide—CYP2E1—lung—esophageal cancer	0.000261	0.0125	CbGeAlD
Methazolamide—Hepatic failure—Methotrexate—esophageal cancer	0.000257	0.0114	CcSEcCtD
Methazolamide—Pancytopenia—Capecitabine—esophageal cancer	0.000254	0.0113	CcSEcCtD
Methazolamide—CYP3A4—digestive system—esophageal cancer	0.000251	0.012	CbGeAlD
Methazolamide—CYP2D6—digestive system—esophageal cancer	0.000247	0.0118	CbGeAlD
Methazolamide—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000244	0.0108	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000237	0.0105	CcSEcCtD
Methazolamide—Ill-defined disorder—Cisplatin—esophageal cancer	0.000235	0.0104	CcSEcCtD
Methazolamide—Malaise—Cisplatin—esophageal cancer	0.000228	0.0101	CcSEcCtD
Methazolamide—Haematuria—Capecitabine—esophageal cancer	0.000228	0.0101	CcSEcCtD
Methazolamide—Leukopenia—Cisplatin—esophageal cancer	0.000227	0.01	CcSEcCtD
Methazolamide—Agranulocytosis—Capecitabine—esophageal cancer	0.000223	0.00986	CcSEcCtD
Methazolamide—CA2—lymph node—esophageal cancer	0.000222	0.0107	CbGeAlD
Methazolamide—Convulsion—Cisplatin—esophageal cancer	0.000219	0.00971	CcSEcCtD
Methazolamide—Discomfort—Cisplatin—esophageal cancer	0.000213	0.00942	CcSEcCtD
Methazolamide—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000208	0.00919	CcSEcCtD
Methazolamide—Anaphylactic shock—Cisplatin—esophageal cancer	0.000207	0.00914	CcSEcCtD
Methazolamide—Erythema multiforme—Capecitabine—esophageal cancer	0.000203	0.00897	CcSEcCtD
Methazolamide—Tinnitus—Capecitabine—esophageal cancer	0.0002	0.00885	CcSEcCtD
Methazolamide—Anorexia—Cisplatin—esophageal cancer	0.000197	0.00872	CcSEcCtD
Methazolamide—Pancytopenia—Methotrexate—esophageal cancer	0.000189	0.00838	CcSEcCtD
Methazolamide—Paraesthesia—Cisplatin—esophageal cancer	0.000186	0.00821	CcSEcCtD
Methazolamide—Dysgeusia—Capecitabine—esophageal cancer	0.000183	0.00809	CcSEcCtD
Methazolamide—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000182	0.00805	CcSEcCtD
Methazolamide—Decreased appetite—Cisplatin—esophageal cancer	0.00018	0.00795	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000178	0.00789	CcSEcCtD
Methazolamide—Drowsiness—Methotrexate—esophageal cancer	0.000178	0.00787	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000176	0.0078	CcSEcCtD
Methazolamide—Ill-defined disorder—Capecitabine—esophageal cancer	0.000173	0.00766	CcSEcCtD
Methazolamide—Feeling abnormal—Cisplatin—esophageal cancer	0.00017	0.00754	CcSEcCtD
Methazolamide—Haematuria—Methotrexate—esophageal cancer	0.00017	0.0075	CcSEcCtD
Methazolamide—Malaise—Capecitabine—esophageal cancer	0.000168	0.00745	CcSEcCtD
Methazolamide—Vertigo—Capecitabine—esophageal cancer	0.000168	0.00742	CcSEcCtD
Methazolamide—Leukopenia—Capecitabine—esophageal cancer	0.000167	0.00739	CcSEcCtD
Methazolamide—Agranulocytosis—Methotrexate—esophageal cancer	0.000166	0.00734	CcSEcCtD
Methazolamide—Body temperature increased—Cisplatin—esophageal cancer	0.000163	0.00723	CcSEcCtD
Methazolamide—Discomfort—Capecitabine—esophageal cancer	0.000157	0.00695	CcSEcCtD
Methazolamide—Confusional state—Capecitabine—esophageal cancer	0.000154	0.0068	CcSEcCtD
Methazolamide—Erythema multiforme—Methotrexate—esophageal cancer	0.000151	0.00668	CcSEcCtD
Methazolamide—Tinnitus—Methotrexate—esophageal cancer	0.000149	0.00659	CcSEcCtD
Methazolamide—Asthenia—Cisplatin—esophageal cancer	0.000148	0.00656	CcSEcCtD
Methazolamide—Anorexia—Capecitabine—esophageal cancer	0.000145	0.00643	CcSEcCtD
Methazolamide—Diarrhoea—Cisplatin—esophageal cancer	0.000141	0.00626	CcSEcCtD
Methazolamide—Paraesthesia—Capecitabine—esophageal cancer	0.000137	0.00605	CcSEcCtD
Methazolamide—Dysgeusia—Methotrexate—esophageal cancer	0.000136	0.00602	CcSEcCtD
Methazolamide—Dyspepsia—Capecitabine—esophageal cancer	0.000134	0.00593	CcSEcCtD
Methazolamide—Decreased appetite—Capecitabine—esophageal cancer	0.000132	0.00586	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000131	0.00582	CcSEcCtD
Methazolamide—Vomiting—Cisplatin—esophageal cancer	0.000131	0.00581	CcSEcCtD
Methazolamide—Fatigue—Capecitabine—esophageal cancer	0.000131	0.00581	CcSEcCtD
Methazolamide—Rash—Cisplatin—esophageal cancer	0.00013	0.00577	CcSEcCtD
Methazolamide—Dermatitis—Cisplatin—esophageal cancer	0.00013	0.00576	CcSEcCtD
Methazolamide—Ill-defined disorder—Methotrexate—esophageal cancer	0.000129	0.0057	CcSEcCtD
Methazolamide—Feeling abnormal—Capecitabine—esophageal cancer	0.000126	0.00555	CcSEcCtD
Methazolamide—Malaise—Methotrexate—esophageal cancer	0.000125	0.00554	CcSEcCtD
Methazolamide—Vertigo—Methotrexate—esophageal cancer	0.000125	0.00552	CcSEcCtD
Methazolamide—Leukopenia—Methotrexate—esophageal cancer	0.000124	0.0055	CcSEcCtD
Methazolamide—Nausea—Cisplatin—esophageal cancer	0.000123	0.00543	CcSEcCtD
Methazolamide—Urticaria—Capecitabine—esophageal cancer	0.000121	0.00536	CcSEcCtD
Methazolamide—Body temperature increased—Capecitabine—esophageal cancer	0.00012	0.00533	CcSEcCtD
Methazolamide—Convulsion—Methotrexate—esophageal cancer	0.00012	0.00533	CcSEcCtD
Methazolamide—Discomfort—Methotrexate—esophageal cancer	0.000117	0.00517	CcSEcCtD
Methazolamide—Confusional state—Methotrexate—esophageal cancer	0.000114	0.00506	CcSEcCtD
Methazolamide—Anaphylactic shock—Methotrexate—esophageal cancer	0.000113	0.00502	CcSEcCtD
Methazolamide—Asthenia—Capecitabine—esophageal cancer	0.000109	0.00484	CcSEcCtD
Methazolamide—Anorexia—Methotrexate—esophageal cancer	0.000108	0.00478	CcSEcCtD
Methazolamide—Diarrhoea—Capecitabine—esophageal cancer	0.000104	0.00461	CcSEcCtD
Methazolamide—Paraesthesia—Methotrexate—esophageal cancer	0.000102	0.00451	CcSEcCtD
Methazolamide—Somnolence—Methotrexate—esophageal cancer	0.000101	0.00446	CcSEcCtD
Methazolamide—Dyspepsia—Methotrexate—esophageal cancer	9.98e-05	0.00442	CcSEcCtD
Methazolamide—Decreased appetite—Methotrexate—esophageal cancer	9.86e-05	0.00436	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Methotrexate—esophageal cancer	9.79e-05	0.00433	CcSEcCtD
Methazolamide—Fatigue—Methotrexate—esophageal cancer	9.78e-05	0.00433	CcSEcCtD
Methazolamide—Vomiting—Capecitabine—esophageal cancer	9.68e-05	0.00429	CcSEcCtD
Methazolamide—Rash—Capecitabine—esophageal cancer	9.6e-05	0.00425	CcSEcCtD
Methazolamide—Dermatitis—Capecitabine—esophageal cancer	9.59e-05	0.00425	CcSEcCtD
Methazolamide—Headache—Capecitabine—esophageal cancer	9.54e-05	0.00422	CcSEcCtD
Methazolamide—Feeling abnormal—Methotrexate—esophageal cancer	9.34e-05	0.00414	CcSEcCtD
Methazolamide—Nausea—Capecitabine—esophageal cancer	9.05e-05	0.004	CcSEcCtD
Methazolamide—Urticaria—Methotrexate—esophageal cancer	9.01e-05	0.00399	CcSEcCtD
Methazolamide—Body temperature increased—Methotrexate—esophageal cancer	8.96e-05	0.00397	CcSEcCtD
Methazolamide—Asthenia—Methotrexate—esophageal cancer	8.13e-05	0.0036	CcSEcCtD
Methazolamide—Diarrhoea—Methotrexate—esophageal cancer	7.76e-05	0.00343	CcSEcCtD
Methazolamide—Vomiting—Methotrexate—esophageal cancer	7.21e-05	0.00319	CcSEcCtD
Methazolamide—Rash—Methotrexate—esophageal cancer	7.15e-05	0.00316	CcSEcCtD
Methazolamide—Dermatitis—Methotrexate—esophageal cancer	7.14e-05	0.00316	CcSEcCtD
Methazolamide—Headache—Methotrexate—esophageal cancer	7.1e-05	0.00314	CcSEcCtD
Methazolamide—Nausea—Methotrexate—esophageal cancer	6.73e-05	0.00298	CcSEcCtD
Methazolamide—CYP2E1—Metabolism—BLVRB—esophageal cancer	2.59e-05	0.000165	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—SLC52A3—esophageal cancer	2.59e-05	0.000165	CbGpPWpGaD
Methazolamide—CA1—Metabolism—CYP19A1—esophageal cancer	2.58e-05	0.000164	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	2.57e-05	0.000164	CbGpPWpGaD
Methazolamide—CA4—Metabolism—HMOX1—esophageal cancer	2.56e-05	0.000163	CbGpPWpGaD
Methazolamide—SLC22A6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	2.55e-05	0.000162	CbGpPWpGaD
Methazolamide—CA4—Metabolism—ABCB1—esophageal cancer	2.46e-05	0.000156	CbGpPWpGaD
Methazolamide—CA2—Metabolism—HMOX1—esophageal cancer	2.46e-05	0.000156	CbGpPWpGaD
Methazolamide—CA14—Metabolism—CREBBP—esophageal cancer	2.45e-05	0.000156	CbGpPWpGaD
Methazolamide—CA9—Metabolism—CYP1B1—esophageal cancer	2.41e-05	0.000153	CbGpPWpGaD
Methazolamide—CA6—Metabolism—CREBBP—esophageal cancer	2.38e-05	0.000152	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—CREBBP—esophageal cancer	2.38e-05	0.000152	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	2.38e-05	0.000151	CbGpPWpGaD
Methazolamide—CA2—Metabolism—ABCB1—esophageal cancer	2.36e-05	0.00015	CbGpPWpGaD
Methazolamide—CA1—Metabolism—HMOX1—esophageal cancer	2.36e-05	0.00015	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	2.35e-05	0.000149	CbGpPWpGaD
Methazolamide—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	2.34e-05	0.000149	CbGpPWpGaD
Methazolamide—CA9—Metabolism—CYP19A1—esophageal cancer	2.27e-05	0.000144	CbGpPWpGaD
Methazolamide—CA1—Metabolism—ABCB1—esophageal cancer	2.26e-05	0.000144	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	2.25e-05	0.000143	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	2.23e-05	0.000142	CbGpPWpGaD
Methazolamide—CA7—Metabolism—CREBBP—esophageal cancer	2.22e-05	0.000141	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—CREBBP—esophageal cancer	2.22e-05	0.000141	CbGpPWpGaD
Methazolamide—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	2.2e-05	0.00014	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CA1—esophageal cancer	2.2e-05	0.00014	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—SLC10A2—esophageal cancer	2.2e-05	0.00014	CbGpPWpGaD
Methazolamide—CA14—Metabolism—NOS3—esophageal cancer	2.19e-05	0.000139	CbGpPWpGaD
Methazolamide—CA6—Metabolism—NOS3—esophageal cancer	2.13e-05	0.000136	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—NOS3—esophageal cancer	2.13e-05	0.000136	CbGpPWpGaD
Methazolamide—CA9—Metabolism—HMOX1—esophageal cancer	2.07e-05	0.000132	CbGpPWpGaD
Methazolamide—CA12—Metabolism—CREBBP—esophageal cancer	2.06e-05	0.000131	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	2.05e-05	0.00013	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CA2—esophageal cancer	2.01e-05	0.000128	CbGpPWpGaD
Methazolamide—CA14—Metabolism—PTGS2—esophageal cancer	2e-05	0.000127	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—BLVRB—esophageal cancer	2e-05	0.000127	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—SLC52A3—esophageal cancer	2e-05	0.000127	CbGpPWpGaD
Methazolamide—CA7—Metabolism—NOS3—esophageal cancer	1.99e-05	0.000127	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—NOS3—esophageal cancer	1.99e-05	0.000127	CbGpPWpGaD
Methazolamide—CA9—Metabolism—ABCB1—esophageal cancer	1.99e-05	0.000126	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—PTGS2—esophageal cancer	1.95e-05	0.000124	CbGpPWpGaD
Methazolamide—CA6—Metabolism—PTGS2—esophageal cancer	1.95e-05	0.000124	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ADH7—esophageal cancer	1.87e-05	0.000119	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PLCE1—esophageal cancer	1.87e-05	0.000119	CbGpPWpGaD
Methazolamide—CA12—Metabolism—NOS3—esophageal cancer	1.85e-05	0.000117	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—SLC52A3—esophageal cancer	1.84e-05	0.000117	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—BLVRB—esophageal cancer	1.84e-05	0.000117	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—PTGS2—esophageal cancer	1.82e-05	0.000116	CbGpPWpGaD
Methazolamide—CA7—Metabolism—PTGS2—esophageal cancer	1.82e-05	0.000116	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—BLVRB—esophageal cancer	1.82e-05	0.000116	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SLC52A3—esophageal cancer	1.82e-05	0.000116	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	1.78e-05	0.000113	CbGpPWpGaD
Methazolamide—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.7e-05	0.000108	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—SLC10A2—esophageal cancer	1.7e-05	0.000108	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CA1—esophageal cancer	1.7e-05	0.000108	CbGpPWpGaD
Methazolamide—CA12—Metabolism—PTGS2—esophageal cancer	1.69e-05	0.000107	CbGpPWpGaD
Methazolamide—CA14—Metabolism—EP300—esophageal cancer	1.67e-05	0.000106	CbGpPWpGaD
Methazolamide—CA4—Metabolism—CREBBP—esophageal cancer	1.64e-05	0.000105	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ADH1B—esophageal cancer	1.64e-05	0.000104	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	1.63e-05	0.000103	CbGpPWpGaD
Methazolamide—CA6—Metabolism—EP300—esophageal cancer	1.62e-05	0.000103	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—EP300—esophageal cancer	1.62e-05	0.000103	CbGpPWpGaD
Methazolamide—CA2—Metabolism—CREBBP—esophageal cancer	1.58e-05	0.0001	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—TYMP—esophageal cancer	1.57e-05	9.97e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CA1—esophageal cancer	1.56e-05	9.93e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—SLC10A2—esophageal cancer	1.56e-05	9.93e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CA2—esophageal cancer	1.55e-05	9.87e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SLC10A2—esophageal cancer	1.55e-05	9.84e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CA1—esophageal cancer	1.55e-05	9.84e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYP26A1—esophageal cancer	1.52e-05	9.7e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.52e-05	9.65e-05	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—EP300—esophageal cancer	1.52e-05	9.64e-05	CbGpPWpGaD
Methazolamide—CA7—Metabolism—EP300—esophageal cancer	1.52e-05	9.64e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—CREBBP—esophageal cancer	1.51e-05	9.61e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ALOX15—esophageal cancer	1.49e-05	9.45e-05	CbGpPWpGaD
Methazolamide—CA4—Metabolism—NOS3—esophageal cancer	1.47e-05	9.36e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PLCE1—esophageal cancer	1.44e-05	9.18e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ADH7—esophageal cancer	1.44e-05	9.18e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CA2—esophageal cancer	1.43e-05	9.08e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.43e-05	9.07e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GSTO1—esophageal cancer	1.42e-05	9.01e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—TPI1—esophageal cancer	1.42e-05	9.01e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CA2—esophageal cancer	1.42e-05	9e-05	CbGpPWpGaD
Methazolamide—CA2—Metabolism—NOS3—esophageal cancer	1.41e-05	8.97e-05	CbGpPWpGaD
Methazolamide—CA12—Metabolism—EP300—esophageal cancer	1.4e-05	8.93e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.38e-05	8.8e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ALDOB—esophageal cancer	1.36e-05	8.64e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—NOS3—esophageal cancer	1.35e-05	8.6e-05	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PTGS2—esophageal cancer	1.35e-05	8.56e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—CREBBP—esophageal cancer	1.33e-05	8.45e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PLCE1—esophageal cancer	1.33e-05	8.44e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ADH7—esophageal cancer	1.33e-05	8.44e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ADH7—esophageal cancer	1.32e-05	8.37e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PLCE1—esophageal cancer	1.32e-05	8.37e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GAPDH—esophageal cancer	1.31e-05	8.32e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.3e-05	8.27e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CRABP1—esophageal cancer	1.3e-05	8.24e-05	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PTGS2—esophageal cancer	1.29e-05	8.21e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ADH1B—esophageal cancer	1.27e-05	8.05e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PTGS2—esophageal cancer	1.24e-05	7.87e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GNG7—esophageal cancer	1.23e-05	7.84e-05	CbGpPWpGaD
Methazolamide—CA14—Metabolism—PIK3CA—esophageal cancer	1.23e-05	7.83e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—TYMP—esophageal cancer	1.21e-05	7.69e-05	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—PIK3CA—esophageal cancer	1.2e-05	7.64e-05	CbGpPWpGaD
Methazolamide—CA6—Metabolism—PIK3CA—esophageal cancer	1.2e-05	7.64e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SLC52A3—esophageal cancer	1.2e-05	7.63e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—BLVRB—esophageal cancer	1.2e-05	7.63e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—NOS3—esophageal cancer	1.19e-05	7.56e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP26A1—esophageal cancer	1.18e-05	7.48e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ADH1B—esophageal cancer	1.16e-05	7.4e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ALDH2—esophageal cancer	1.16e-05	7.35e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ADH1B—esophageal cancer	1.15e-05	7.34e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ALOX15—esophageal cancer	1.15e-05	7.29e-05	CbGpPWpGaD
Methazolamide—CA7—Metabolism—PIK3CA—esophageal cancer	1.12e-05	7.13e-05	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—PIK3CA—esophageal cancer	1.12e-05	7.13e-05	CbGpPWpGaD
Methazolamide—CA4—Metabolism—EP300—esophageal cancer	1.12e-05	7.12e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—TYMP—esophageal cancer	1.11e-05	7.07e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—TYMP—esophageal cancer	1.1e-05	7.01e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GSTT1—esophageal cancer	1.1e-05	6.99e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GSTO1—esophageal cancer	1.09e-05	6.95e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—TPI1—esophageal cancer	1.09e-05	6.95e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PTGS2—esophageal cancer	1.09e-05	6.92e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYP2A6—esophageal cancer	1.09e-05	6.91e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP26A1—esophageal cancer	1.08e-05	6.88e-05	CbGpPWpGaD
Methazolamide—CA2—Metabolism—EP300—esophageal cancer	1.07e-05	6.83e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP26A1—esophageal cancer	1.07e-05	6.82e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ALOX15—esophageal cancer	1.05e-05	6.7e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ALDOB—esophageal cancer	1.05e-05	6.67e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ALOX15—esophageal cancer	1.05e-05	6.65e-05	CbGpPWpGaD
Methazolamide—CA12—Metabolism—PIK3CA—esophageal cancer	1.04e-05	6.6e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PTGS1—esophageal cancer	1.03e-05	6.55e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ENO1—esophageal cancer	1.03e-05	6.55e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—EP300—esophageal cancer	1.03e-05	6.54e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.02e-05	6.49e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CA1—esophageal cancer	1.02e-05	6.49e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PSME1—esophageal cancer	1.01e-05	6.45e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PSME2—esophageal cancer	1.01e-05	6.45e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GAPDH—esophageal cancer	1.01e-05	6.42e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GSTO1—esophageal cancer	1.01e-05	6.4e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—TPI1—esophageal cancer	1.01e-05	6.4e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CRABP1—esophageal cancer	1e-05	6.36e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GSTO1—esophageal cancer	9.97e-06	6.34e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—TPI1—esophageal cancer	9.97e-06	6.34e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ALDOB—esophageal cancer	9.64e-06	6.13e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ALDOB—esophageal cancer	9.56e-06	6.08e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GNG7—esophageal cancer	9.51e-06	6.05e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CA2—esophageal cancer	9.33e-06	5.94e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GAPDH—esophageal cancer	9.28e-06	5.9e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GAPDH—esophageal cancer	9.2e-06	5.85e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CRABP1—esophageal cancer	9.2e-06	5.85e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CRABP1—esophageal cancer	9.12e-06	5.8e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—EP300—esophageal cancer	9.05e-06	5.75e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ALDH2—esophageal cancer	8.91e-06	5.67e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYP1B1—esophageal cancer	8.76e-06	5.57e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GNG7—esophageal cancer	8.75e-06	5.56e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ADH7—esophageal cancer	8.68e-06	5.52e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PLCE1—esophageal cancer	8.68e-06	5.52e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GNG7—esophageal cancer	8.67e-06	5.52e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GSTT1—esophageal cancer	8.48e-06	5.39e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP2A6—esophageal cancer	8.38e-06	5.33e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.35e-06	5.31e-05	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PIK3CA—esophageal cancer	8.28e-06	5.27e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYP19A1—esophageal cancer	8.23e-06	5.24e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ALDH2—esophageal cancer	8.2e-06	5.21e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ALDH2—esophageal cancer	8.13e-06	5.17e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ENO1—esophageal cancer	7.95e-06	5.05e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PTGS1—esophageal cancer	7.95e-06	5.05e-05	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PIK3CA—esophageal cancer	7.94e-06	5.05e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PSME1—esophageal cancer	7.83e-06	4.98e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PSME2—esophageal cancer	7.83e-06	4.98e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GSTT1—esophageal cancer	7.8e-06	4.96e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GSTT1—esophageal cancer	7.73e-06	4.92e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP2A6—esophageal cancer	7.71e-06	4.9e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP2A6—esophageal cancer	7.64e-06	4.86e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	7.61e-06	4.84e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PIK3CA—esophageal cancer	7.61e-06	4.84e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ADH1B—esophageal cancer	7.61e-06	4.84e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—HMOX1—esophageal cancer	7.51e-06	4.78e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ENO1—esophageal cancer	7.31e-06	4.65e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PTGS1—esophageal cancer	7.31e-06	4.65e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—TYMP—esophageal cancer	7.27e-06	4.62e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PTGS1—esophageal cancer	7.24e-06	4.61e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ENO1—esophageal cancer	7.24e-06	4.61e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ABCB1—esophageal cancer	7.21e-06	4.59e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PSME1—esophageal cancer	7.2e-06	4.58e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PSME2—esophageal cancer	7.2e-06	4.58e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PSME2—esophageal cancer	7.14e-06	4.54e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PSME1—esophageal cancer	7.14e-06	4.54e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP26A1—esophageal cancer	7.07e-06	4.5e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ALOX15—esophageal cancer	6.89e-06	4.38e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.84e-06	4.35e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP1B1—esophageal cancer	6.76e-06	4.3e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PIK3CA—esophageal cancer	6.69e-06	4.26e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTO1—esophageal cancer	6.58e-06	4.18e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—TPI1—esophageal cancer	6.58e-06	4.18e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP19A1—esophageal cancer	6.35e-06	4.04e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ALDOB—esophageal cancer	6.3e-06	4.01e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.23e-06	3.96e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP1B1—esophageal cancer	6.21e-06	3.95e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP1B1—esophageal cancer	6.16e-06	3.92e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GAPDH—esophageal cancer	6.07e-06	3.86e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CRABP1—esophageal cancer	6.01e-06	3.82e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP19A1—esophageal cancer	5.84e-06	3.72e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—HMOX1—esophageal cancer	5.8e-06	3.69e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP19A1—esophageal cancer	5.79e-06	3.68e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GNG7—esophageal cancer	5.72e-06	3.64e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.69e-06	3.62e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ABCB1—esophageal cancer	5.56e-06	3.54e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ALDH2—esophageal cancer	5.36e-06	3.41e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—HMOX1—esophageal cancer	5.33e-06	3.39e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—HMOX1—esophageal cancer	5.29e-06	3.36e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.18e-06	3.3e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ABCB1—esophageal cancer	5.12e-06	3.25e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTT1—esophageal cancer	5.1e-06	3.24e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ABCB1—esophageal cancer	5.07e-06	3.23e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP2A6—esophageal cancer	5.04e-06	3.21e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CREBBP—esophageal cancer	4.82e-06	3.06e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ENO1—esophageal cancer	4.78e-06	3.04e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PTGS1—esophageal cancer	4.78e-06	3.04e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PSME1—esophageal cancer	4.71e-06	2.99e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PSME2—esophageal cancer	4.71e-06	2.99e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—NOS3—esophageal cancer	4.32e-06	2.74e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.21e-06	2.67e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP1B1—esophageal cancer	4.06e-06	2.58e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PTGS2—esophageal cancer	3.95e-06	2.51e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.84e-06	2.44e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.82e-06	2.43e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CREBBP—esophageal cancer	3.72e-06	2.36e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.49e-06	2.22e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CREBBP—esophageal cancer	3.42e-06	2.17e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CREBBP—esophageal cancer	3.39e-06	2.16e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.35e-06	2.13e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NOS3—esophageal cancer	3.33e-06	2.12e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—EP300—esophageal cancer	3.28e-06	2.09e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NOS3—esophageal cancer	3.06e-06	1.95e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PTGS2—esophageal cancer	3.04e-06	1.94e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NOS3—esophageal cancer	3.04e-06	1.93e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PTGS2—esophageal cancer	2.8e-06	1.78e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PTGS2—esophageal cancer	2.78e-06	1.77e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—EP300—esophageal cancer	2.53e-06	1.61e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PIK3CA—esophageal cancer	2.43e-06	1.54e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—EP300—esophageal cancer	2.33e-06	1.48e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—EP300—esophageal cancer	2.31e-06	1.47e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.24e-06	1.42e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NOS3—esophageal cancer	2e-06	1.27e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PIK3CA—esophageal cancer	1.87e-06	1.19e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.83e-06	1.16e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PIK3CA—esophageal cancer	1.72e-06	1.1e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PIK3CA—esophageal cancer	1.71e-06	1.09e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—EP300—esophageal cancer	1.52e-06	9.68e-06	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.13e-06	7.16e-06	CbGpPWpGaD
